PATENT CLAIM ANALYSIS

Application Number: 15883075
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-08
Patent Classification: ["705", "002000"]

Abstract:
This embodiment reduces the chances of interactions between Prescriptions (Rx's), received from medical professionals, and over-the counter vitamins, minerals and/or supplements. These interactions could reduce the effectiveness, and/or cause dangerous reactions. The interaction could provide guidance of when to take, not to take or how to take the Prescriptions (Rx's) and/or over-the counter vitamins, minerals and/or supplements. This embodiment also reduces the interaction to the patient's existing Rx's and previous Rx's. If drug interactions are identified the onsite pharmacist will be notified. The pharmacist will review drug interactions, if any, with the Rx (dosage, frequency of taking drug, etc.) and over-the-counter drugs, and discuss with the customer, if necessary.

Claim (Index 12):
The method in  claim 11  will determine if a drug interaction is indicated and an alert will be given to the on-site pharmacist and/or the customer/patient.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 86.0
- Lexical Diversity: 2.01449
- Patent Class: 705.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13645086', '13143172', '12191759', '10382388', '10418229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.0910843180684336
- 35 USC 102 Novelty (BERT): 0.4796010356761161
- Combined Prediction Score: 0.1299359898292018
- Mean Citation Score: 45.2656654
- Max Citation Score: 47.328327
- Similarity Product: 27.22835222245896

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test